What is holding us back from making the needed changes to intellectual property policy with regard to healthcare?
How does intellectual property affect innovation incentives (both positively and negatively)? What are the trade-offs? Who is protected by intellectual property and who is vulnerable to harm?
Are new spaces for intervention and influence opening up now for activists to activate in the intellectual property and health nexus? What are those opportunities?